Promising Novel Therapeutics for Strokes and Cardiac Maladies

Accessibility Controls

Implementing Organization

Institute of Microbial Technology (IMTECH)

Project Overview

PEGylated-streptokinase find wide application in novel therapeutics for Strokes and Cardiac Maladies.

Benefits

This is a cutting-edge technology that has a truly international potential since it can compete with the most advanced clot-buster drug currently available (TPA, tissue plasminogen activator), The technology will be sufficiently scaled-up in-house so that after transfer to a commercial partner it has a minimum take-off period.

Source

Source URL

www.imtech.res.in

Related Research

View All

Quick Information

Thrust Areas

Medical Sciences

Focus Area

Therapy for Strokes & Cardiac Maladies

Output

TRL: Technology Readiness Level

Lab Validation

Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.

Accessibility Controls

All Technologies